Please login to the form below

Not currently logged in
Email:
Password:

IGAS

This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.

Novartis’ iptacopan scores positive results in rare blood disorder PNH

Novartis’ iptacopan scores positive results in rare blood disorder PNH

involvement. This includes IgA nephropathy (IgAN), atypical haemolytic uremic syndrome (aHUS), and membranous nephropathy (MN). ... The European Medicines Agency (EMA) has also granted iptacopan a PRIME designation in C3G, as well as an orphan drug

Latest news

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....